Haemonetics Corporation
HAE
$56.66
-$1.80-3.08%
NYSE
| 12/27/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/28/2024 | |
|---|---|---|---|---|---|
| Net Income | 44.74M | 38.68M | 34.03M | 57.98M | 37.49M |
| Total Depreciation and Amortization | 27.39M | 28.26M | 28.76M | 21.51M | 29.03M |
| Total Amortization of Deferred Charges | -- | -- | -- | 6.70M | -- |
| Total Other Non-Cash Items | 9.63M | 18.29M | 10.09M | -10.63M | 12.57M |
| Change in Net Operating Assets | 11.81M | 26.09M | -55.48M | 40.99M | -35.32M |
| Cash from Operations | 93.56M | 111.32M | 17.40M | 116.56M | 43.77M |
| Capital Expenditure | -6.35M | -5.02M | -3.75M | -15.64M | -8.55M |
| Sale of Property, Plant, and Equipment | 432.00K | 120.00K | 297.00K | 2.45M | 251.00K |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | 43.29M | -- |
| Other Investing Activities | -23.55M | -25.57M | -29.54M | -12.06M | -9.08M |
| Cash from Investing | -29.47M | -30.47M | -33.00M | 18.04M | -17.37M |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -1.56M | -1.56M | -1.56M | -1.56M | -1.56M |
| Issuance of Common Stock | 3.77M | 63.00K | 3.94M | 140.00K | 3.54M |
| Repurchase of Common Stock | -160.00K | -75.01M | -4.78M | -150.00M | -449.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -14.00K | -39.00K | -36.00K | -27.00K | -149.00K |
| Cash from Financing | 2.03M | -76.55M | -2.44M | -151.45M | 1.38M |
| Foreign Exchange rate Adjustments | 810.00K | -773.00K | 4.18M | 2.77M | -6.21M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 66.94M | 3.53M | -13.87M | -14.08M | 21.56M |